The drug ublituximab beat a standard oral medication for MS in reducing patients' relapses and proved better at preventing areas of inflammatory damage in the brain.
from WebMD Health https://www.webmd.com/multiple-sclerosis/news/20220825/new-ms-treatment-shows-promise-in-trial?src=RSS_PUBLIC
0 Comments:
Post a Comment